- Advertisement -
Infant formula company Bubs Australia (ASX: BUB) has sharply downgraded its full-year revenue guidance to between $105 million and $115 million as regulatory hurdles, geopolitical disruption in the Middle East and competitive pressures weigh on the business.
The target is down from a range of…
Click here to view the original article.
